The concentrates segment, by product type, is projected to grow at the highest CAGR during the forecast period. This is majorly due to the varied number of forms in which concentrates are made available for consumption. Some of these forms are shatter, rosin, wax, crumble, oil, dabs, and tinctures. Additionally, concentrates are more potent in nature in comparison with flowers. While buds have a potency range of about 10% to 25%, concentrates have a potency rate of about 50% to 80%, with a few extracts also boasting of a potency rate of about 90%. Concentrates also enjoy a wide variety of delivery methods such as smoking, vaping, dabbing, ingestion, and tinctures. These delivery methods further aid the market growth of concentrates.
Report Objectives:
• Determining and projecting the size of the market with respect to product type, application, compound, and region, over a five-year period ranging from 2018 to 2023
• Identifying attractive opportunities in the market by determining the largest and fastest-growing segments across regions
• Providing detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• Analyzing the micromarkets with respect to individual growth trends, future prospects, and their contribution to the total market
• Identifying and profiling key market players in the cannabis market
• Providing a comparative analysis of the market leaders on the basis of the following:
o Product offerings
o Business strategies
o Strengths and weaknesses
o Key financials
• Understanding the competitive landscape and identifying the major growth strategies adopted by players across the key regions
• Analyzing the supply chain, products, and regulatory frameworks across regions and their impact on the prominent market players
• Providing insights on key innovations and investments in the market
The recreational segment, by application, is projected to grow at a higher CAGR during the forecast period. Uruguay is the only country in South America to have legalized the use of recreational cannabis. The cannabis market is projected to remain concentrated in the US and Canada. Despite its low availability in various countries, the consumption and demand levels remain equivalent to that of medicinal cannabis. As a result, the demand for recreational cannabis is projected to surpass the demand for medical cannabis. For instance, medical cannabis is legalized mainly in 33 states of the US. However, only 10 states in the country have legalized recreational cannabis, and its consumption level is almost equivalent to the consumption level of medical cannabis across the 33 states. Therefore, the legalization of recreational cannabis across other regions could translate into a larger market share for this segment.
In terms of geographical coverage, the cannabis market has been segmented into 4 regions, namely, North America, South America, Europe, RoW (Rest of the World). Europe is projected to record the highest growth rate during the forecast period. The market in Europe is still in its introductory stage and has significant potential due to its population, which is even higher than the US and Canada combined. However, most market players such as Aphria, Inc. (Canada) and Terra Tech Corp. (US) have an established and well-networked market for cannabis in the Americas, with the majority of their revenues being generated from the US and Canada, making the North American market the most dominant one.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.